Mainstay Medical Holdings plc
Mainstay Medical Holdings plc, headquartered in Ireland (IE), is a pioneering company in the medical device industry, specialising in innovative solutions for chronic pain management. Founded in 2008, Mainstay has made significant strides with its flagship product, the ReActiv8 system, which offers a unique approach to treating patients with intractable chronic low back pain. With a focus on neuromodulation, Mainstay Medical operates primarily in Europe and the United States, positioning itself as a leader in the field of implantable medical devices. The company’s commitment to advancing patient care is reflected in its robust clinical evidence and regulatory achievements, establishing a strong market presence. Mainstay Medical continues to drive innovation, aiming to improve the quality of life for patients suffering from debilitating pain conditions.
DitchCarbon Score
How does Mainstay Medical Holdings plc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mainstay Medical Holdings plc's score of 18 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Mainstay Medical Holdings plc's reported carbon emissions
Mainstay Medical Holdings plc, headquartered in Ireland (IE), currently does not have available data on its carbon emissions, as no specific emissions figures have been reported. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the absence of concrete emissions data, it is essential to note that many companies in the medical technology sector are increasingly focusing on sustainability and climate commitments. This trend often includes setting science-based targets for emissions reductions and implementing initiatives to enhance energy efficiency and reduce overall carbon footprints. As the industry evolves, Mainstay Medical may consider establishing its own climate commitments to align with these emerging standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Mainstay Medical Holdings plc is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
